登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：600318 证券简称：新力金融 公告编号：临2025-036 安徽新力金融股份有限公司关于召开2025年半年度业绩说明会的预告公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 重要内容提示： 会议召开时间：2025年10月16日（星期四）10:00-11:00 会议召开地点：上海证券交易所上证路演中心（网址：https://roadshow.sseinfo.com/） 会议召开方式：上证路演中心网络互动 本次投资者说明会以网络互动形式召开，公司将针对2025年半年度的经营成果及财务指标的具体情况与 投资者进行互动交流和沟通，在信息披露允许的范围内就投资者普遍关注的问题进行回答。 二、说明会召开的时间、地点 （一）会议召开时间：2025年10月16日（星期四）10:00-11:00 （二）会议召开地点：上证路演中心（http://roadshow.sseinfo.com/） （三）会议召开方式：上证路演中心网络互动 三、参加人员 董事长、总经理：孟庆立先生 投资者 ...

Core Viewpoint - The company, Anhui Wanwei High New Materials Co., Ltd., anticipates a significant increase in net profit for the first three quarters of 2025, projecting a growth of 69.81% to 109.77% compared to the same period last year [1][3]. Performance Forecast - The expected net profit attributable to shareholders for the first three quarters of 2025 is estimated to be between 340 million yuan and 420 million yuan, an increase of 139.78 million yuan to 219.78 million yuan year-on-year [3]. - The projected net profit, excluding non-recurring gains and losses, is expected to be between 324 million yuan and 404 million yuan, reflecting a year-on-year increase of 143.88 million yuan to 223.88 million yuan [3]. Previous Year Performance - In the same period last year, the net profit attributable to shareholders was 200.22 million yuan, and the net profit after excluding non-recurring gains and losses was 180.12 million yuan [5]. Reasons for Performance Increase - The company has adjusted its sales strategy, leading to a steady increase in foreign trade market share, with PVA export volume increasing by over 40% and acetic acid methyl export volume rising by approximately 30% [7]. - The company has focused on high-value-added new materials in the PVA downstream sector, enhancing R&D investment and breaking through foreign monopolies in certain products, resulting in strong sales and profitability for new materials like PVA optical films [7]. - A significant decline in the prices of raw materials such as coal, acetic acid, and PTA has improved the gross margins of products like PVA and polyester chips, enhancing profitability [7]. - The company has strengthened cost control and steadily advanced cost reduction and efficiency improvement, leading to enhanced operational efficiency [7].

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：001332 证券简称：锡装股份 公告编号：2025-043 无锡化工装备股份有限公司 第四届董事会第十六次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏。 一、董事会会议召开情况 无锡化工装备股份有限公司（以下简称"公司"）第四届董事会第十六次会议（临时会议）通知已于2025 年9月19日通过电子邮件或电话等方式送达所有董事，会议于2025年9月23日15:30在公司三楼会议室以 现场会议结合通讯方式召开。本次会议应到董事7名，实到董事7名，公司高级管理人员列席参会。会议 由董事长曹洪海先生主持。本次会议的召集和召开符合《中华人民共和国公司法》和《公司章程》的相 关规定。 二、董事会会议审议情况 （一）审议通过了《关于使用自有资金进行委托理财的议案》。 表决结果：7票同意，0票反对，0票弃权。 董事会认为公司合理使用自有资金进行委托理财，不会影响公司主营业务的正常开展，有利于提高闲置 资金的收益，符合公司和全体股东的利益，不存在损害公司及全体股东特别是中小股东的利益的情形。 董事会同意公 ...

证券代码：603501 证券简称：豪威集团 公告编号：2025-093 转债代码：113616 转债简称：韦尔转债 豪威集成电路（集团）股份有限公司 关于2023年第一期股票期权激励计划 第二个行权期符合行权条件的实施公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 重要内容提示： ● 本次股票期权第二个行权期拟行权数量：2,561,099份 ● 行权股票来源：公司向激励对象定向发行公司A股普通股 豪威集成电路（集团）股份有限公司（以下简称"公司"）于2025年9月12日召开第七届董事会第五次会 议，审议通过了《关于2023年第一期股票期权激励计划第二个行权期符合行权条件的议案》等相关议 案，公司根据《2023年第一期股票期权激励计划》（以下简称"《激励计划》"）授予的股票期权第二个 行权期的行权条件已成就。 一、2023年第一期股票期权激励计划批准及实施情况 （一）2023年第一期股票期权激励计划方案 公司2023年第一期股票期权激励计划（以下简称"本激励计划"）共向777名激励对象授予7,716,850份股 票期权，股 ...

Group 1 - The company held its fifth board meeting on September 24, 2025, where all five directors attended, and the meeting was deemed legally valid [1][3]. - The board approved a proposal to acquire 71% of Sichuan Yindile Material Technology Group Co., Ltd. through a combination of issuing shares and cash payment, along with raising supporting funds [1][13]. - The proposal was passed with a vote of 3 in favor, 0 against, and 2 abstentions, with related directors recusing themselves from the vote [3][4][8]. Group 2 - The company plans to sign a supplementary agreement for a performance compensation agreement with ten counterparties involved in the transaction, including Zhuhai Hengqin Xufan Investment Management Partnership and Jiangsu Yuanyu Electronic Investment Group [7][9]. - This supplementary agreement was also approved with the same voting results as the previous proposal [8][10]. - The board had previously received authorization from the shareholders' meeting to handle all matters related to this transaction without needing further shareholder approval [10][11]. Group 3 - The company has responded to the Shanghai Stock Exchange's inquiry regarding the asset acquisition and has made necessary revisions to the transaction report [14][17]. - The transaction is subject to approval from the Shanghai Stock Exchange and the China Securities Regulatory Commission before implementation [14][17]. - The company will continue to fulfill its information disclosure obligations as the transaction progresses [14].

证券代码：688789 证券简称：宏华数科 公告编号：2025-042 杭州宏华数码科技股份有限公司 关于向特定对象发行股票募投项目结项 二、募集资金投资项目情况 根据公司披露的《杭州宏华数码科技股份有限公司2022年度向特定对象发行A股股票募集说明书（注册 稿）》，公司2022年度向特定对象发行A股股票（以下简称"本次发行"）募集资金投资项目及使用计划 如下： 单位：万元 并将节余募集资金永久补充流动资金的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性依法承担法律责任。 杭州宏华数码科技股份有限公司（以下简称"公司"或"宏华数科"）于2025年9月24日召开第八届董事会 第二次会议，审议通过了《关于向特定对象发行股票募投项目结项并将节余募集资金永久补充流动资金 的议案》，同意公司向特定对象发行股票募集资金投资项目（以下简称"募投项目"）"年产3,520套工业 数码喷印设备智能化生产线"结项，并将节余募集资金（含利息收入）16,326.14万元（实际金额以资金 转出当日计算的该项目募集资金剩余金额为准）用于永久补充流动资金。保荐机构中 ...

Group 1 - The company has proposed to reappoint Tianjian Accounting Firm as the auditor for the fiscal year 2025, ensuring continuity and stability in audit work [2][53][74] - The board of directors and the supervisory board have both approved the proposal to reappoint Tianjian Accounting Firm, which will be submitted for shareholder approval [8][9][75] - The audit fees for 2024 were set at 800,000 yuan, with 600,000 yuan for financial report auditing and 200,000 yuan for internal control auditing [7] Group 2 - Tianjian Accounting Firm has a good investor protection capability, with a cumulative compensation limit exceeding 200 million yuan for professional risk funds and insurance [3] - The firm has faced four administrative penalties and 13 supervisory measures in the past three years, but has not faced criminal penalties [4] - The firm and its partners have maintained independence and have not faced any situations that could affect their independence [6][7] Group 3 - The company will hold its first extraordinary general meeting of 2025 on October 10, 2025, to discuss the reappointment of the accounting firm and other matters [12][69] - The meeting will be conducted both in-person and online, with specific voting procedures outlined for shareholders [13][15] - The company aims to enhance service for small and medium investors by providing reminders for the meeting and voting [16]

Core Viewpoint - Chongqing Sifang New Materials Co., Ltd. plans to use up to 200 million yuan of idle raised funds to temporarily supplement working capital for business related to its main operations, with a usage period not exceeding 12 months from the board's approval date [2][7]. Fundraising Basic Situation - The company raised a total of 1.32499 billion yuan from its initial public offering, with a net amount of 1.235123 billion yuan after deducting issuance costs of 89.869 million yuan [2][3]. Previous Use of Idle Funds - As of the announcement date, the company has not yet returned a total of 545 million yuan of previously used idle funds to the fundraising account, which includes several approvals for temporary working capital supplementation [3][4][5]. Current Plan for Fund Usage - The company aims to improve the efficiency of fund usage and reduce operational costs by using up to 200 million yuan of idle funds for temporary working capital, ensuring that the funds will be returned to the original fundraising account before the usage period expires [7][8]. Decision-Making Process - The proposal to use idle funds was approved by the company's fourth board of directors and the audit committee, complying with relevant regulations and ensuring no change in the purpose of the raised funds [8][10].

证券代码：688202 证券简称：美迪西 公告编号：2025-062 上海美迪西生物医药股份有限公司 关于开立募集资金专户并签署募集 资金专户存储三方监管协议的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性依法承担法律责任。 一、募集资金基本情况 根据中国证券监督管理委员会（以下简称"中国证监会"）于2023年2月7日出具的《关于同意上海美迪西 生物医药股份有限公司向特定对象发行股票注册的批复》（证监许可[2023]265号），同意上海美迪西 生物医药股份有限公司（以下简称"公司"）向特定对象发行A股股票的注册申请。截至2023年8月4日 止，公司募集资金总额人民币100,000.00万元，扣除承销保荐费等各项发行费用1,470.93万元（不含增值 税）后，实际募集资金净额为人民币98,529.07万元。立信会计师事务所（特殊普通合伙）对公司向特定 对象发行A股股票的资金到位情况进行了审验，并出具了《上海美迪西生物医药股份有限公司验资报 告》（信会师报字[2023]第ZA14977号）。募集资金到账后，已全部存放于募集资金专项账户内， ...

证券代码：688350 证券简称：富淼科技 公告编号：2025-065 转债代码：118029 转债简称：富淼转债 江苏富淼科技股份有限公司 关于"富淼转债"可选择回售的第二次提示性公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容的 真实性、准确性和完整性依法承担法律责任。 重要内容提示： ●回售价格：100.46元人民币/张（含当期利息） ●回售期：2025年9月23日至2025年9月29日 ●风险提示：可转债持有人选择回售等同于以100.46元人民币/张（含当期利息）卖出持有的"富淼转 债"。截至本公告披露日，"富淼转债"的收盘价格高于本次回售价格，可转债持有人选择回售可能会带 来一定经济损失，敬请投资者注意风险。 根据中国证券监督管理委员会于2022年11月14日核发的《关于同意江苏富淼科技股份有限公司向不特定 对象发行可转债注册的批复》（证监许可[2022]2757号），江苏富淼科技股份有限公司（以下简称"公 司"或"富淼科技"）向不特定对象发行可转债450.00万张，每张面值为人民币100元，按面值发行。本次 发行募集资金总额为45,000.00万元，扣 ...